Lung Cancer Screening: One for All or All for One?
Journal of Current Oncological Trends · 2025
DOI: 10.4103/jcot.jcot_12_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Oncological Trends, 2025. Verfasst von Amitabh Ray und 3 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Lung cancer remains the leading cause of cancer-related mortality worldwide. Despite advances in treatment, the high fatality rate results from a typically late diagnosis. Screening and early detection have become critical strategies to reduce mortality by identifying lung cancer at an earlier, manageable stage. This review summarizes the evolving landscape of lung cancer screening, presents key evidence from major trials, evaluates the benefits and challenges of low-dose computed tomography, discusses the integration of biomarkers and artificial intelligence, and highlights the challenges in deploying these advances in diverse populations, including India.
Zitieren
APA
Ray, A., Mazumdar, K., Kundu, S., & Mallick, C. (2025). Lung Cancer Screening: One for All or All for One?. Journal of Current Oncological Trends. https://doi.org/10.4103/jcot.jcot_12_25
Vancouver
Ray A, Mazumdar K, Kundu S, Mallick C. Lung Cancer Screening: One for All or All for One?. Journal of Current Oncological Trends. 2025. doi:10.4103/jcot.jcot_12_25
BibTeX
@article{Ray2025,
author = {Ray, Amitabh and Mazumdar, Koustav and Kundu, Sayan and Mallick, Chandrani},
title = {Lung Cancer Screening: One for All or All for One?},
journal = {Journal of Current Oncological Trends},
year = {2025},
doi = {10.4103/jcot.jcot_12_25}
}
EUVIMED